NDC Active Ingredient Rituximab

  1. Home
  2. NDC Active Ingredient Index
  3. Rituximab

Active Ingredient Information

What is Rituximab?

A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.

What is the usage for Rituximab?

Rituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). It works by slowing or stopping the growth of cancer cells. Some brands of rituximab are also used to treat rheumatoid arthritis and can decrease joint pain and swelling. This drug is also used to treat certain types of blood vessel disease (such as granulomatosis with polyangiitis, microscopic polyangiitis) and can decrease the swelling of the blood vessels. Rituximab is also used to treat a certain skin condition (pemphigus vulgaris). It helps to reduce the number of skin lesions. This monograph is about the following rituximab products: rituximab, rituximab-abbs, and rituximab-pvvr.

How many products in the NDC database contain Rituximab?

The NDC database has 18 products with the active ingredient Rituximab. The following table lists all the products that have this active ingredient.

NDC Products with Rituximab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0238Proprietary Name: Ruxience Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0069-0249Proprietary Name: Ruxience Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
50242-051Proprietary Name: Rituxan RituximabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-052Proprietary Name: RituximabLiquidGenentech, Inc.ACTIVE
50242-053Proprietary Name: Rituxan RituximabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-108Proprietary Name: Rituxan Hycela Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-109Proprietary Name: Rituxan Hycela Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
55513-224Proprietary Name: Riabni Rituximab-arrxInjection, SolutionIntravenousAmgen IncACTIVE
55513-326Proprietary Name: Riabni Rituximab-arrxInjection, SolutionIntravenousAmgen IncACTIVE
63459-103Proprietary Name: Truxima Rituximab-abbsInjection, SolutionIntravenousCephalon, Inc.ACTIVE
63459-104Proprietary Name: Truxima Rituximab-abbsInjection, SolutionIntravenousCephalon, Inc.ACTIVE
69443-007Proprietary Name: Rituximab-arrxInjection, SolutionBaxter Oncology GmbhACTIVE
69443-010Proprietary Name: Rituximab-arrxInjection, SolutionBaxter Oncology GmbhACTIVE
69443-013Proprietary Name: Rituximab-arrxInjection, SolutionBaxter Oncology GmbhACTIVE
69443-016Proprietary Name: Rituximab-arrxInjection, SolutionBaxter Oncology GmbhACTIVE
69443-101Proprietary Name: Rituximab-abbsInjection, Solution, ConcentrateBaxter Oncology GmbhACTIVE
69443-103Proprietary Name: Rituximab-abbsInjection, Solution, ConcentrateBaxter Oncology GmbhACTIVE
71124-0003Proprietary Name: RituximabLiquidSamsung Biologics Co., Ltd.ACTIVE
<